HDFC Bank CEO Moves Bombay HC to Quash Bribery FIR Filed by Lilavati Trust
HDFC Bank Managing Director and CEO Sashidhar Jagdishan has approached the Bombay High Court seeking the quashing of a First Information Report (FIR) filed against him by the Lilavati Kirtilal Mehta Medical Trust, which operates Mumbai’s renowned Lilavati Hospital. The FIR accuses Jagdishan of accepting a ₹2.05 crore bribe to allegedly aid the Chetan Mehta group in maintaining control over the Trust’s operations. However, a division bench of Justices A.S. Gadkari and Rajesh Patil has recused itself from hearing the matter, pending reassignment.
The legal dispute escalated further after the Trust issued a public statement on June 9, 2025, detailing alleged misconduct by Jagdishan. These include claims of free medical treatment received by his family at Lilavati Hospital, misuse of ₹1.5 crore in CSR funds, and inconsistencies in HDFC Bank’s declarations about loan amounts—citing varying figures of ₹4.8 crore, ₹450 crore, and ₹65.22 crore without supporting documents. The Trust reiterated that it has no borrowing relationship with HDFC Bank and has deposited ₹48 crore in fixed deposits and bonds since FY2022.
In response, HDFC Bank has strongly denied the allegations, calling them “egregiously malicious, false and defamatory.” A spokesperson for the bank emphasized that neither the institution nor its CEO has engaged in any wrongdoing and hinted at taking legal action against the trustees for defamation. Meanwhile, the Trust has reportedly initiated civil and criminal defamation proceedings amounting to over ₹1,000 crore against Jagdishan.
Pic Courtesy: google/ images are subject to copyright
